Document Detail


Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.
MedLine Citation:
PMID:  20628426     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Vascular remodeling, characterized by extracellular matrix deposition and increased media-to-lumen (M/L) ratio, contributes to the development of microvascular complications in diabetes. We have previously shown in type 2 diabetic Goto-Kakizaki (GK) rats that selective ETA receptor blockade prevents medial thickening of mesenteric arteries via regulation of matrix metalloproteases (MMP), whereas selective ETB receptor blockade augments this thickening. The goal of this study was to determine the effect of combined ETA and ETB receptor blockade on resistance vessel remodeling. Vessel structure, MMP activity, and extracellular matrix proteins were assessed in control Wistar and diabetic GK rats treated with vehicle or bosentan (100 mg/kg per day) for 4 weeks (n = 7-9 per group). Bosentan completely prevented the increase in M/L ratio and MMP-2 activity in diabetes but paradoxically increased M/L ratio and MMP activation in control animals. Collagenase (MMP-13) activity and protein levels were significantly decreased in diabetes. Accordingly, collagen deposition was augmented in GK rats. Dual ET receptor antagonism improved enzyme activity and normalized MMP-13 levels in diabetic animals but blunted MMP-13 activity in control animals. In summary, current findings suggest that diabetes-mediated remodeling of resistance arteries is prevented by dual blockade of ETA and ETB receptors and that the relative role of ET receptors in the regulation of vascular structure differs in the control and disease states.
Authors:
Kamakshi Sachidanandam; Vera Portik-Dobos; Aisha I Kelly-Cobbs; Adviye Ergul
Related Documents :
3071486 - Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired i...
1988056 - Identification and characterization of the ligand-binding domain of insulin receptor by...
17063326 - Insulin sensitivity and resistin expression in nitric oxide-deficient rats.
7417516 - Responses of rat and chick chondrocytes and rate hepatoma cells to plasma fractions wit...
3914416 - Changes in blood glucose and insulin after an oral palatinose administration in normal ...
2054146 - Levoprotiline ((-)-oxaprotiline) effects on inositol phosphate generation in human peri...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Canadian journal of physiology and pharmacology     Volume:  88     ISSN:  1205-7541     ISO Abbreviation:  Can. J. Physiol. Pharmacol.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-07-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372712     Medline TA:  Can J Physiol Pharmacol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  616-21     Citation Subset:  IM    
Affiliation:
Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Athens, Georgia, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
R01 DK074385/DK/NIDDK NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glucose-induced endothelin-1 expression is regulated by ERK5 in the endothelial cells and retina of ...
Next Document:  Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory ...